Handelsbanken Fonder
RDY icon

Handelsbanken Fonder’s Dr. Reddy's Laboratories RDY Stock Holding History

Handelsbanken Fonder’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,966
Closed -$182K – 1518
2025
Q4 		$182K Buy
+12,966
New +$182K ﹤0.01% 1490

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Handelsbanken Fonder's RDY Position: Q1 2026 in Review

Handelsbanken Fonder sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 12,966 shares — an estimated $182K sold.

Handelsbanken Fonder first reported a position in RDY in Q4 2025 and held it in 1 quarter. The position peaked at $182K in Q4 2025. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Handelsbanken Fonder reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Handelsbanken Fonder sold 12,966 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $182K.
  • Handelsbanken Fonder first reported a position in Dr. Reddy's Laboratories in Q4 2025 and held it in 1 quarter.
  • Handelsbanken Fonder's Dr. Reddy's Laboratories position peaked at $182K in Q4 2025.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Handelsbanken Fonder's 13F filing for Q1 2026, filed 28 Apr 2026.